"Designing Growth Strategies is in our DNA"

Influenza Medication Market Size, Share, Trends & Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI101843

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Overview of Influenza Epidemiology
    2. Analysis of Disease Burden of Influenza, By Key Regions
    3. New Product Launches
    4. Pipeline Analysis
    5. Analysis of the Impact of the Launch of Generics on the Influenza Medication Market
    6. Key Industry Developments
  5. Global Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis, Insights and Forecast – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2024)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. Genentech, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      2. Shionogi & Co., Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      3. Seqirus (CSL)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      4. BIOCRYST PHARMACEUTICALS, INC.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      5. GlaxoSmithKline plc
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      6. Lupin Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      7. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      8. Zydus Pharmaceuticals, Inc. (Zydus Cadila)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      9. Amneal Pharmaceuticals LLC
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      10. Macleods Pharmaceuticals Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      11. Alvogen
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      12. Others
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
  12. Strategic Recommendations
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Overview of Influenza Epidemiology
    2. Analysis of Disease Burden of Influenza, By Key Regions
    3. New Product Launches
    4. Pipeline Analysis
    5. Analysis of the Impact of the Launch of Generics on the Influenza Medication Market
    6. Key Industry Developments
  5. Global Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis, Insights and Forecast – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Influenza Medication Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Baloxavir marboxil
      2. Oseltamivir phosphate
      3. Others
    3. Market Analysis – By Influenza Type
      1. Influenza A
      2. Influenza B
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2024)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. Genentech, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      2. Shionogi & Co., Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      3. Seqirus (CSL)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      4. BIOCRYST PHARMACEUTICALS, INC.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      5. GlaxoSmithKline plc
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      6. Lupin Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      7. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      8. Zydus Pharmaceuticals, Inc. (Zydus Cadila)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      9. Amneal Pharmaceuticals LLC
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      10. Macleods Pharmaceuticals Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      11. Alvogen
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      12. Others
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Influenza Medication Market Revenue Breakdown (US$ Mn, %) by Region, 2024-2032

Figure 2:  Global Influenza Medication Market Value Share (%), by Treatment, 2024-2032

Figure 3:  Global Influenza Medication Market Forecast (US$ Mn), by Baloxavir marboxil, 2019-2032

Figure 4:  Global Influenza Medication Market Forecast (US$ Mn), by Oseltamivir phosphate, 2019-2032

Figure 5:  Global Influenza Medication Market Forecast (US$ Mn), by Others, 2019-2032

Figure 6:  Global Influenza Medication Market Value Share (%), by Influenza Type, 2024-2032

Figure 7:  Global Influenza Medication Market Forecast (US$ Mn), by Influenza A, 2019-2032

Figure 8:  Global Influenza Medication Market Forecast (US$ Mn), by Influenza B, 2019-2032

Figure 9:  Global Influenza Medication Market Value Share (%), by Route of Administration, 2024-2032

Figure 10:  Global Influenza Medication Market Forecast (US$ Mn), by Oral, 2019-2032

Figure 11:  Global Influenza Medication Market Forecast (US$ Mn), by Others, 2019-2032

Figure 12:  Global Influenza Medication Market Value Share (%), by Distribution Channel, 2024-2032

Figure 13:  Global Influenza Medication Market Forecast (US$ Mn), by Hospital Pharmacies, 2019-2032

Figure 14:  Global Influenza Medication Market Forecast (US$ Mn), by Retail Pharmacies, 2019-2032

Figure 15:  Global Influenza Medication Market Forecast (US$ Mn), by Online Pharmacies, 2019-2032

Figure 16:  Global Influenza Medication Market Forecast (US$ Mn), by Others, 2019-2032

Figure 17:  Global Influenza Medication Market Value (US$ Mn), by Region, 2024-2032

Figure 18:  North America Influenza Medication Market Value (US$ Mn), by Treatment, 2024-2032

Figure 19:  North America Influenza Medication Market Value Share (%), by Treatment, 2024

Figure 20:  North America Influenza Medication Market Value (US$ Mn), by Influenza Type, 2024-2032

Figure 21:  North America Influenza Medication Market Value Share (%), by Influenza Type, 2024

Figure 22:  North America Influenza Medication Market Value (US$ Mn), by Route of Administration, 2024-2032

Figure 23:  North America Influenza Medication Market Value Share (%), by Route of Administration, 2024

Figure 24:  North America Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2024-2032

Figure 25:  North America Influenza Medication Market Value Share (%), by Distribution Channel, 2024

Figure 26:  North America Influenza Medication Market Value (US$ Mn), By Country, 2024-2032

Figure 27:  North America Influenza Medication Market Value Share (%), By Country, 2024

Figure 28:  Europe Influenza Medication Market Value (US$ Mn), by Treatment, 2024-2032

Figure 29:  Europe Influenza Medication Market Value Share (%), by Treatment, 2024

Figure 30:  Europe Influenza Medication Market Value (US$ Mn), by Influenza Type, 2024-2032

Figure 31:  Europe Influenza Medication Market Value Share (%), by Influenza Type, 2024

Figure 32:  Europe Influenza Medication Market Value (US$ Mn), by Route of Administration, 2024-2032

Figure 33:  Europe Influenza Medication Market Value Share (%), by Route of Administration, 2024

Figure 34:  Europe Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2024-2032

Figure 35:  Europe Influenza Medication Market Value Share (%), by Distribution Channel, 2024

Figure 36:  Europe Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2024-2032

Figure 37:  Europe Influenza Medication Market Value Share (%), By Country/ Sub-region, 2024

Figure 38:  Asia Pacific Influenza Medication Market Value (US$ Mn), by Treatment, 2024-2032

Figure 39:  Asia Pacific Influenza Medication Market Value Share (%), by Treatment, 2024

Figure 40:  Asia Pacific Influenza Medication Market Value (US$ Mn), by Influenza Type, 2024-2032

Figure 41:  Asia Pacific Influenza Medication Market Value Share (%), by Influenza Type, 2024

Figure 42:  Asia Pacific Influenza Medication Market Value (US$ Mn), by Route of Administration, 2024-2032

Figure 43:  Asia Pacific Influenza Medication Market Value Share (%), by Route of Administration, 2024

Figure 44:  Asia Pacific Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2024-2032

Figure 45:  Asia Pacific Influenza Medication Market Value Share (%), by Distribution Channel, 2024

Figure 46:  Asia Pacific Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2024-2032

Figure 47:  Asia Pacific Influenza Medication Market Value Share (%), By Country/ Sub-region, 2024

Figure 48:  Latin America Influenza Medication Market Value (US$ Mn), by Treatment, 2024-2032

Figure 49:  Latin America Influenza Medication Market Value Share (%), by Treatment, 2024

Figure 50:  Latin America Influenza Medication Market Value (US$ Mn), by Influenza Type, 2024-2032

Figure 51:  Latin America Influenza Medication Market Value Share (%), by Influenza Type, 2024

Figure 52:  Latin America Influenza Medication Market Value (US$ Mn), by Route of Administration, 2024-2032

Figure 53:  Latin America Influenza Medication Market Value Share (%), by Route of Administration, 2024

Figure 54:  Latin America Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2024-2032

Figure 55:  Latin America Influenza Medication Market Value Share (%), by Distribution Channel, 2024

Figure 56:  Latin America Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2024-2032

Figure 57:  Latin America Influenza Medication Market Value Share (%), By Country/ Sub-region, 2024

Figure 58:  Middle East & Africa Influenza Medication Market Value (US$ Mn), by Treatment, 2024-2032

Figure 59:  Middle East & Africa Influenza Medication Market Value Share (%), by Treatment, 2024

Figure 60:  Middle East & Africa Influenza Medication Market Value (US$ Mn), by Influenza Type, 2024-2032

Figure 61:  Middle East & Africa Influenza Medication Market Value Share (%), by Influenza Type, 2024

Figure 62:  Middle East & Africa Influenza Medication Market Value (US$ Mn), by Route of Administration, 2024-2032

Figure 63:  Middle East & Africa Influenza Medication Market Value Share (%), by Route of Administration, 2024

Figure 64:  Middle East & Africa Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2024-2032

Figure 65:  Middle East & Africa Influenza Medication Market Value Share (%), by Distribution Channel, 2024

Figure 66:  Middle East & Africa Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2024-2032

Figure 67:  Middle East & Africa Influenza Medication Market Value Share (%), By Country/ Sub-region, 2024

Figure 68:  Global Influenza Medication Market Share (%), By Company, 2024

Table 1:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2019–2032

Table 2:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2019–2032

Table 3:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2019–2032

Table 4:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019–2032

Table 5:  Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Region, 2019-2032

Table 6:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 7:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2019-2032

Table 8:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2019-2032

Table 9:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 10:  North America Influenza Medication Market Revenue (US$ Mn) Forecast, By Country, 2019-2032

Table 11:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 12:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2019-2032

Table 13:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2019-2032

Table 14:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 15:  Europe Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 16:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 17:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2019-2032

Table 18:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2019-2032

Table 19:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 20:  Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 21:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 22:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2019-2032

Table 23:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2019-2032

Table 24:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 25:  Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 26:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2019-2032

Table 27:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2019-2032

Table 28:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2019-2032

Table 29:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 30:  Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Influenza Medication Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 145
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports